Diagnostic Procedures in Tularaemia with Special Focus on Molecular and Immunological Techniques
- 1 August 2005
- journal article
- review article
- Published by Wiley in Journal of Veterinary Medicine, Series B
- Vol. 52 (6) , 249-261
Abstract
Summary: Tularaemia is a severe bacterial zoonosis caused by the highly infectious agent Francisella tularensis. It is endemic in countries of the northern hemisphere ranging from North America to Europe, Asia and Japan. Very recently, Francisella‐like strains causing disease in humans were described from tropical northern Australia. In the last decade, efforts have been made to develop sensitive and specific immunological and molecular techniques for the laboratory diagnosis of tularaemia and also for the definite identification of members of the species F. tularensis and its four subspecies. Screening for the keyword ‘Francisella’ a Medline search over the last decade was performed and articles describing diagnostic methods for tularaemia and its causative agent were selected. Besides classical microbiological techniques (cultivation, biochemical profiling, susceptibility testing) several new immunological and molecular approaches to identify F. tularensis have been introduced employing highly specific antibodies and various polymerase chain reaction (PCR)‐based methods. Whereas direct antigen detection by enzyme‐linked immunosorbent assay (ELISA) or immunofluorescence might allow early presumptive diagnosis of tularaemia, these methods – like all PCR techniques – still await further evaluation. Therefore, diagnosis of tularaemia still relies mainly on the demonstration of specific antibodies in the host. ELISA and immunoblot methods started to replace the standard tube or micro‐agglutination assays. However, the diagnostic value of antibody detection in the very early clinical phase of tularaemia is limited. Francisella tularensis is regarded as a ‘highest priority’ biological agent (category ‘A’ according to the CDC, Atlanta, GA, USA), thus rapid and reliable diagnosis of tularaemia is required not only for a timely onset of therapy, the handling of outbreak investigations but also for the surveillance of endemic foci. Only very recently, evaluated test kits for serological diagnosis of human tularaemia became available, while the introduction of standardized molecular techniques for detection and typing is still missing.Keywords
This publication has 93 references indexed in Scilit:
- Genotyping of Francisella tularensis Strains by Pulsed-Field Gel Electrophoresis, Amplified Fragment Length Polymorphism Fingerprinting, and 16S rRNA Gene SequencingJournal of Clinical Microbiology, 2002
- Exposure of Laboratory Workers to Francisella tularensis despite a Bioterrorism ProcedureJournal of Clinical Microbiology, 2002
- Extensive Allelic Variation among Francisella tularensis Strains in a Short-Sequence Tandem Repeat RegionJournal of Clinical Microbiology, 2001
- Waterborne Outbreak of Tularemia Associated with Crayfish FishingEmerging Infectious Diseases, 2001
- Immunogenicity of a new lot ofFrancisella tularensislive vaccine strain in human volunteersFEMS Immunology & Medical Microbiology, 1996
- Field investigations of tularemia in NorwayFEMS Immunology & Medical Microbiology, 1996
- Production and Partial Characterization of Hybridoma Clones Secreting Monoclonal Antibodies Against Francisella tularensisHybridoma, 1993
- Production of Murine Monoclonal Antibodies against Francisella tularensis Antigens and Characterization of Antibody-Reactive EpitopesInternational Archives of Allergy and Immunology, 1989
- Enhancing recovery of Francisella tularensis from bloodDiagnostic Microbiology and Infectious Disease, 1988
- Detection of antigen in urine of a patient with TularemiaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987